Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is evaluation of the efficiency of pelvic floor muscles in the context of surgical outcomes in the treatment of stress urinary incontinence and pelvic organ prolapse.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pelvic floor surgery | The group will consist of females with pelvic floor disorders (pelvic organ prolapse, stress urinary incontinence) qualified for pelvic floor surgery |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Pelvic Floor Distress Inventory (PFDI-20) | Symptom inventory and a measure of the degree of bother and distress. The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300. | change from the baseline till 6 months post treatment |
| Pelvic floor organ prolapse quantification (POP-Q) | Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes | change from the baseline till 6 month post treatment |
| Marshall-Bonney test | Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence | change from the baseline till 6 months post treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Pelvic Floor Distress Inventory (PFDI-20) | Symptom inventory and a measure of the degree of bother and distress. The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300. | 3 months post treatment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- previous surgical interventions due to stress urinary incontinence or pelvic organ prolapse
Not provided
participant eligibility is based on self-representation of gender identity.
Women with stress urinary incontinence and pelvic organ prolapse
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dorota Sys, PhD | Centre of Postgraduate Medical Education | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centrum Medyczne "ŻELAZNA" | Warsaw | 01-004 | Poland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37819368 | Derived | Szymanski JK, Starzec-Proserpio M, Bartosinska-Raczkiewicz D, Krawczyk A, Kukulski P, Jakiel G. Impact of preoperative pelvic floor muscle function on the success of surgical treatment of pelvic organ prolapse. Int Urogynecol J. 2024 Jan;35(1):85-93. doi: 10.1007/s00192-023-05653-8. Epub 2023 Oct 11. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014550 | Urinary Incontinence, Stress |
| D056887 | Pelvic Organ Prolapse |
| D059952 | Pelvic Floor Disorders |
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Pelvic Floor Distress Inventory (PFDI-20) | Symptom inventory and a measure of the degree of bother and distress. The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300. | 12 months post treatment |
| Pelvic Floor Distress Inventory (PFDI-20) | Symptom inventory and a measure of the degree of bother and distress. The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300. | change from the baseline till 3 months post treatment |
| Pelvic Floor Distress Inventory (PFDI-20) | Symptom inventory and a measure of the degree of bother and distress. The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300. | change from the baseline till 12 months post treatment |
| Visual Analogue Scale | Distress assessment range 0-10, higher numbers represent better outcomes | 3 month post treatment |
| Visual Analogue Scale | Distress assessment range 0-10, higher numbers represent better outcomes | 6 months post treatment |
| Visual Analogue Scale | Distress assessment range 0-10, higher numbers represent better outcomes | 12 months post treatment |
| Visual Analogue Scale | Distress assessment range 0-10, higher numbers represent better outcomes | change from the baseline till 3 months post treatment |
| Visual Analogue Scale | Distress assessment range 0-10, higher numbers represent better outcomes | change from the baseline till 6 months post treatment |
| Visual Analogue Scale | Distress assessment range 0-10, higher numbers represent better outcomes | change from the baseline till 12 months post treatment |
| PELVIC FLOOR IMPACT QUESTIONNAIRE SHORT FORM (PFIQ-7) | Assessment of life impact in women with pelvic floor disorders, range 0-300, higher numbers indicate greater impact | 3 month post treatment |
| PELVIC FLOOR IMPACT QUESTIONNAIRE SHORT FORM (PFIQ-7) | Assessment of life impact in women with pelvic floor disorders, range 0-300, higher numbers indicate greater impact | 6 months post treatment |
| PELVIC FLOOR IMPACT QUESTIONNAIRE SHORT FORM (PFIQ-7) | Assessment of life impact in women with pelvic floor disorders, range 0-300, higher numbers indicate greater impact | 12 months post treatment |
| PELVIC FLOOR IMPACT QUESTIONNAIRE SHORT FORM (PFIQ-7) | Assessment of life impact in women with pelvic floor disorders, range 0-300, higher numbers indicate greater impact | change from the baseline till 3 months post treatment |
| PELVIC FLOOR IMPACT QUESTIONNAIRE SHORT FORM (PFIQ-7) | Assessment of life impact in women with pelvic floor disorders, range 0-300, higher numbers indicate greater impact | change from the baseline till 6 months post treatment |
| PELVIC FLOOR IMPACT QUESTIONNAIRE SHORT FORM (PFIQ-7) | Assessment of life impact in women with pelvic floor disorders, range 0-300, higher numbers indicate greater impact | change from the baseline till 12 months post treatment |
| Incontinence impact Questionnaire-Short Form (IIQ-7 SF) | To measure the impact of urinary incontinence on activities, roles and emotional states | 3 months post treatment |
| Incontinence impact Questionnaire-Short Form (IIQ-7 SF) | To measure the impact of urinary incontinence on activities, roles and emotional states | 6 months post treatment |
| Incontinence impact Questionnaire-Short Form (IIQ-7 SF) | To measure the impact of urinary incontinence on activities, roles and emotional states | 12 months post treatment |
| Incontinence impact Questionnaire-Short Form (IIQ-7 SF) | To measure the impact of urinary incontinence on activities, roles and emotional states | change from the baseline till 3 months post treatment |
| Incontinence impact Questionnaire-Short Form (IIQ-7 SF) | To measure the impact of urinary incontinence on activities, roles and emotional states | change from the baseline till 6 months post treatment |
| Incontinence impact Questionnaire-Short Form (IIQ-7 SF) | To measure the impact of urinary incontinence on activities, roles and emotional states | change from the baseline till 12 months post treatment |
| Pelvic floor organ prolapse quantification (POP-Q) | Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes | at 1 month post treatment |
| Pelvic floor organ prolapse quantification (POP-Q) | Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes | 3 months post treatment |
| Pelvic floor organ prolapse quantification (POP-Q) | Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes | 12 months post treatment |
| Pelvic floor organ prolapse quantification (POP-Q) | Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes | change from the baseline till 3 month post treatment |
| Pelvic floor organ prolapse quantification (POP-Q) | Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes | change from the baseline till 12 month post treatment |
| Pelvic floor organ prolapse quantification (POP-Q) | Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes | change from the baseline till 1 month post treatment |
| Marshall-Bonney test | Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence | at 1 month post treatment |
| Marshall-Bonney test | Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence | 3 months post treatment |
| Marshall-Bonney test | Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence | 12 months post treatment |
| Marshall-Bonney test | Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence | change from the baseline till 3 months post treatment |
| Marshall-Bonney test | Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence | change from the baseline till 1 month post treatment |
| Marshall-Bonney test | Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence | change from the baseline till 12 months post treatment |
| Pelvic Floor Distress Inventory (PFDI-20) | Symptom inventory and a measure of the degree of bother and distress. The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300. | 6 months post treatment |
| Pelvic floor organ prolapse quantification (POP-Q) | Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes | 6 months post treatment |
| Marshall-Bonney test | Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence | 6 months post treatment |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D011391 | Prolapse |
| D020763 | Pathological Conditions, Anatomical |
| D011248 | Pregnancy Complications |